Back to Top Skip to main content Skip to sub-navigation

You also may be interested in...

P&T Meetings 2002

Meeting Reference
11/21/2002

Cumulative Minutes from the DoD P&T Committee Meetings for 2002

P&T Executive Council - November 2002

Meeting Reference
11/20/2002

Minutes for the DoD P&T Executive Committee Meeting from November 2002

Big Jack, Phase B

Fact Sheet
10/31/2002

The purpose of the Big Jack, Phase B test was to obtain information on the degree of penetration of jungle canopy by a chemical warfare agent simulant disseminated from an operational type weapon system.

Red Oak, Phase I

Fact Sheet
10/31/2002

The purposes of Red Oak, Phase I were to determine the height-of-burst distributions of the 121A1 (155mm) chemical projectiles and the M55 (115mm) rocket warheads when fired into a jungle environment, and to determine the effects of fragmentation from bursting chemical munitions.

Yellow Leaf

Fact Sheet
10/31/2002

TThe first objective of the Yellow Leaf test was to determine the effectiveness of the M143 bomblet when employed against targets in a jungle environment. The second objective was to determine mathematically, and based on data obtained from the Yellow Leaf test, the area coverage to be expected from the detonation of a US Navy MISTEYE I weapons system or a US Army SERGEANT M211 biological warhead over a jungle canopy.

Pin Point

Fact Sheet
10/31/2002

The purposes of Pin Point were to evaluate the riot-control-agent CS-dispensing, man- portable E8 launcher and the aerially-delivered CBU-19/A and CBU-30/A munitions for area-coverage-time-dosage relationships in a tropical jungle environment.

Big Jack, Phase A

Fact Sheet
10/31/2002

The purpose of the Big Jack, Phase A test was to measure penetration of a jungle canopy bybiological and chemical agent simulants disseminated from an operational weapon system.

Department of Defense Policy on Reprocessing of Medical Single Use Devices

Policy
  • Identification #: 02-020
  • Date: 10/18/2002
  • Type: Memorandums
  • Topics: N/A

Senate Armed Services Committee, Subcommittee on Personnel, Prepare Statement of Dr. William Winkenwerder, Jr., Assistant Secretary of Defense for Health Affairs, on Shipboard Hazard and Defense

Policy

Prepared Statement of the Honorable William Winkenwerder, Jr., M.D., M.B.A on Shipboard Hazard and Defense

Congressional Testimony
10/10/2002

Testimony before the Senate Armed Services Committee

Military Operations Aspects of SHAD and Project 112

Publication
10/9/2002

Hearing before the Subcommittee on Health of the Committee on Veterans' Affairs, House of Representatives, 107th Congress, 2nd Session

West Side, Phase II

Fact Sheet
10/9/2002

The purpose of West Side, Phase II was to evaluate the area coverage capabilities of the A/B 45-Y-4/F-105 powdered agent dissemination system as used operationally over a northern open plains region during cold weather.

Devil Hole, Phase 2

Fact Sheet
10/9/2002

Devil Hole, Phase II was conducted in temperate aspen and spruce forested terrain to provide weapons effects information for artillery delivered VX nerve agent-filled shells. The munitions used were M121A1 (155m) and M426 (8-inch) artillery shells filled with VX nerve agent.

Deseret Test Center Test 69-14

Fact Sheet
10/9/2002

The purpose of DTC Test 69-14 was to determine the hazards associated with inadvertent release of the MC-1 bomb during takeoff and landing, as well as the hazards resulting from bomb damage caused by hostile fire.

Pine Ridge

Fact Sheet
10/9/2002

The purposes of Pine Ridge were to ascertain the percentage of BLU-19/B23 and BLU-20/B23 bomblets that function and to determine their dissemination points in or below a jungle canopy; to determine area-time-dosage and diffusion characteristics of agent BZ and Sarin nerve agent when disseminated from single bomblets; and, to estimate the effective area coverage that could be expected if agent BZ and Sarin nerve agent were disseminated from single or multiple SUU-13/A dispenser loads.

<< < ... 1096 1097 1098 1099 1100  ... > >> 
Showing results 16426 - 16440 Page 1096 of 1144
Refine your search
Last Updated: September 15, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.